Search Results - Cruickshank, Mark

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

    Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic... by Cheung, Laurence, Cruickshank, Mark N, Hughes, Anastasia M, Singh, Sajla, Chua, Grace-Alyssa, Ford, Jette, Ferrari, Emanuela, Oommen, Joyce, Malinge, Sébastien, Lock, Richard B, Kees, Ursula R, Kotecha, Rishi S

    Published 2019
    Get full text
    Get full text
  2. 2
    Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia.

    Identifying the optimal donor for natural killer cell adoptive therapy to treat paediatric B- and T-cell acute lymphoblastic leukaemia. by Foley, Bree, Ta, Clara, Barnes, Samantha, de Jong, Emma, Nguyen, Michelle, Cheung, Laurence, Buzzai, Anthony, Wagner, Teagan, Wylie, Ben, Fernandez, Sonia, Cruickshank, Mark, Endersby, Raelene, Kees, Ursula, Waithman, Jason

    Published 2020
    Get full text

Search Tools: